B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

Clinical trial NCT05515185 · UNKNOWN

Trial details

NCT number: NCT05515185
Sponsor: The First People's Hospital of Lianyungang
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-09-09
Primary completion: 2024-09-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.